Quantum Genomics Quantum Genomics
  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Shareholder letter
    • General meetings
    • Shareholding
    • Financial calendar
    • Contacts
  • Contact us
News

Quantum Genomics will Present Top-line Results from its QUORUM study at European Society of Cardiology (ESC) Meeting

Quantum on 21 April 2021

Quantum Genomics will Present Top-line Results from its QUORUM study European Society of Cardiology (ESC) Meeting

Read the press realease

Previous Post (p) Quantum Genomics Reports Full Year 2020 Operating and Financial Results
Next Post (n) Quantum Genomics Secures €3 Million Non-dilutive Financing
Quantum 2021-04-21T08:04:31+02:00
About

Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure.

Contact us

33 rue Marbeuf
75008 Paris

[email protected]
+33(0)1 85 34 77 70

Write us

Quick access
  • Scientific Publications
Search

 

© 2019 Quantum Genomics - Legal notice - Website terms and conditions

  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Shareholder letter
    • General meetings
    • Shareholding
    • Financial calendar
    • Contacts
  • Contact us
  • Blog
  • Home
  • Contact us